期刊文献+

某院质子泵抑制剂应用情况分析 被引量:13

原文传递
导出
摘要 目的:对本院质子泵抑制剂使用情况进行分析,为临床合理用药提供参考。方法:查阅病程记录及住院医嘱,对291份使用质量泵抑制剂病历的适应证、给药方案及途径进行统计与分析。结论:质量泵抑制剂存在过度使用,使用时应做到有理有据,避免无指征用药。
作者 王华 周鹏
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第21期1808-1810,共3页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献7

  • 1周斌,金慧萍,迟丹怡.质子泵抑制剂概述[J].中国药业,2004,13(5):77-80. 被引量:25
  • 2SAHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. SAHP Cornmi.ssion on Therapeutics and approved by the SAHP Board of Directors on Noveeber 14, 1998 [J]. Am J Health Syst Pharm, 1999,56 : 347-379.
  • 3Targownik LE, Lix LM, Metge CJ, et al. Use of proton pupm inhibitors and risk of osteoporosis-related fractures[J]. CMAJ, 2008,179(4) :319-326.
  • 4He PM, Maddox TM,Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[J]. JAMA,2009, 301(9):937.
  • 5陈玫芬,陈辉邦.注射用泮托拉唑钠在4种输液中的配伍稳定性[J].海峡药学,2005,17(5):20-22. 被引量:25
  • 6吴蓉,周刚.幽门螺杆菌三联根除疗法影响因素的Logistic回归分析[J].中国全科医学,2011,14(26):2981-2983. 被引量:12
  • 7Greevasingna N, Pat rick L, Coleman, et al. Proton pump inhibi- tors and acute interstitial nephritis[J]. Clin Gastroenter Hepa- tol, 2006,4 : 597-604.

二级参考文献20

  • 1王娟.三种给药方案治疗幽门螺杆菌感染所致消化性溃疡的成本—效果分析[J].疑难病杂志,2007,6(9):541-543. 被引量:10
  • 2Graham DY.Campylobacter pylori and peptic ulcer disease[J].Gastroenterology,1989,96(2 Pt 2 Suppl):615-625.
  • 3Lai CH,Kuo CH,Chen PY,et al.Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates[J].J Antimicrob Chemother,2006,57(3):466-471.
  • 4Wermeille J,Cunningham M,Dederding JP,et al.Failure of Helicobacter pylori eradication:is poor compliance the main cause[J].Gastroenterol Clin Biol,2002,26(3):216-219.
  • 5Hooton C,Dempsey C,Keohane J,et al.Helicobacter pylori:prevalence of anti-microbial resistance in clinical isolates[J].Br J Biomed Sci,2006;63(3):113-116.
  • 6Dzieniszewski J,Jarosz M.Guidelines in the medical treatment of Helicobacter pylori infection[J].J Physiol Pharmacol,2006,57(Suppl 3):143-154.
  • 7Georgopoulos SD,Ladas SD,Karatapanis S,et al.Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole,amoxy -cillin,and clari-thromycin[J].Dig Dis Sci,2000,45(1):63-67.
  • 8Duck WM,Sobel J,Pruckler JM,et al.Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons,United States[J].Emerg Infect Dis,2004,10(6):1088-1094.
  • 9Sipponen P,Kekki M,Seppala K,et al.The relationship between chronic gastritis and gastric acid secretion[J].Aliment Pharmacol Ther,1996,10(Suppl 1):103-118.
  • 10Tray G,Marks IN,Louw JA,et al.Changes in acid secretion over the years,a 30-year longitudinal study[J].J clin Gastroenterol,1997,25(3):499-502.

共引文献59

同被引文献101

  • 1Hiroki Morita,Erito Mochiki,Nobuyuki Takahashi,Kiyoshi Kawamura,Akira Watanabe,Toshinaga Sutou,Atsushi Ogawa,Mitsuhiro Yanai,Kyoichi Ogata,Takaaki Fujii,Tetsuro Ohno,Souichi Tsutsumi,Takayuki Asao,Hiroyuki Kuwano.Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs[J].World Journal of Gastroenterology,2013,19(39):6604-6612. 被引量:9
  • 2陈玫芬,陈辉邦.注射用泮托拉唑钠在4种输液中的配伍稳定性[J].海峡药学,2005,17(5):20-22. 被引量:25
  • 3中华医学杂志编辑委员会.应激性溃疡防治建议[J].中华医学杂志,2002,82:1000-1001.
  • 4Lo EA,Wilby KJ,Ensom MH.Use of proton pump inhibitors in the management of gastroesophageal varices:a systematic review[J].Ann Pharmacother,2015,49(2):207-219.
  • 5Reeve E,Andrews JM,Wiese MD,et al.Feasibility of a patientcentered deprescribing process to reduce inappropriate use of proton pump inhibitors[J].Ann Pharmacother,2015,49(1):29-38.
  • 6Naunton M,Peterson GM,Bleterson GM,et al.Overuse pf proton pump inhibitors[J].J Clin Pharm Ther,2000,25(5):330-340.
  • 7Walker NM,Mc Donald J.An evaluation of the use of proton pump inhibitors[J].Pharm World Sci,2001,23(3):116-117.
  • 8Thachil J.Overprescribing PPIs:Time for a hospital antacid policy on Clostridium difficile[J].BMJ,2008,336(7636):109.
  • 9Earnshaw SR,Scheiman J,Fendrick AM,et al.Cost-utility of aspirin and proton pump inhibitors for primary prevention[J].Arch Intern Med,2011,171(3):218-225.
  • 10Wang CH,Ma MH,Chou HC,et al.High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer:a systematic review and meta-analysis of randomized controlled trials[J].Arch Intern Med,2010,170(9):751-758.

引证文献13

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部